Could Teligent Inc (NASDAQ:TLGT) Go Up After Its Newest Short Interest Report?

June 12, 2018 - By Adrian Mccoy

The stock of Teligent Inc (NASDAQ:TLGT) registered an increase of 2.85% in short interest. TLGT’s total short interest was 7.58M shares in June as published by FINRA. Its up 2.85% from 7.37M shares, reported previously. With 1.03M shares average volume, it will take short sellers 7 days to cover their TLGT’s short positions. The short interest to Teligent Inc’s float is 19.73%.

The stock increased 2.47% or $0.08 during the last trading session, reaching $3.3. About 263,460 shares traded. Teligent, Inc. (NASDAQ:TLGT) has declined 67.87% since June 12, 2017 and is downtrending. It has underperformed by 80.44% the S&P500.

Teligent, Inc., a specialty generic pharmaceutical company, develops, formulates, makes, and markets generic topical, branded generic, and generic injectable pharmaceutical products in the United States and Canada. The company has market cap of $176.56 million. The firm sells generic pharmaceutical products in topical, injectable, complex, and ophthalmic dosage forms. It currently has negative earnings. It also develops, makes, fills, and packages topical semi-solid and liquid products for branded and generic pharmaceutical customers, as well as for over-the-counter and cosmetic markets.

More news for Teligent, Inc. (NASDAQ:TLGT) were recently published by: Nasdaq.com, which released: “Investor Expectations to Drive Momentum within Sun Communities, Anheuser-Busch InBev SA/NV, New Media …” on May 17, 2018. Globenewswire.com‘s article titled: “Teligent, Inc. Announces Closing Of $25 Million Secured Credit Facility” and published on June 05, 2018 is yet another important article.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: